Traditional Chinese Medicine for Alzheimer's Disease and Other Cognitive Impairment: A Review
- PMID: 32329645
- DOI: 10.1142/S0192415X20500251
Traditional Chinese Medicine for Alzheimer's Disease and Other Cognitive Impairment: A Review
Abstract
Cognitive impairment (CI) refers to the dysfunction of memory, language, visual space, execution, calculation, understanding, and judgment in one or more aspects. With global aging, CI will become prevalent worldwide. At present, there is no effective cure for CI. However, Nobel laureate Tu Youyou's research on artemisinin has inspired Chinese researchers to focus on traditional Chinese herbs (TCHs) for the treatment of CI. Traditional Chinese Medicine (TCM) has led to a theory for an independent CI system. The pathogenesis of such impairment involves deficiency, phlegm, and stagnation and involves a range of organs, including the brain, kidneys, heart, liver, and spleen. Our current understanding of the etiology and pathogenesis of this condition has led to the realization that TCHs can improve cognitive dysfunction. Clinical research has shown that TCHs can improve the neuropsychological scale score of patients, the TCM symptom score, and the patient's quality of life. Research has also suggested that TCHs can retard A deposits and tauopathy, regulate the metabolism of cholinergic neurotransmitters, and so on. However, due to their complexity, little is known of the safety and efficacy of TCHs in patients with CI. It is likely that we will be able to identify the precise mechanisms associated with the action of TCHs in such patients due to the integration of multiple technologies. This paper summarizes the pharmacokinetics, curative effect, and mechanisms of action of traditional Chinese herbs in order to provide a scientific basis for the improvement of cognitive dysfunction by TCHs.
Keywords: Action Mechanism; Cognitive Impairment; Pharmacokinetics; Review; Traditional Chinese Herbs.
Similar articles
-
Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology.J Ethnopharmacol. 2020 Mar 1;249:112433. doi: 10.1016/j.jep.2019.112433. Epub 2019 Nov 27. J Ethnopharmacol. 2020. PMID: 31783135
-
Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine.Clin Interv Aging. 2023 Jun 17;18:963-986. doi: 10.2147/CIA.S414714. eCollection 2023. Clin Interv Aging. 2023. PMID: 37351381 Free PMC article. Review.
-
Long-term efficacy of Chinese medicine Bushen Capsule on cognition and brain activity in patients with amnestic mild cognitive impairment.Pharmacol Res. 2019 Aug;146:104319. doi: 10.1016/j.phrs.2019.104319. Epub 2019 Jun 17. Pharmacol Res. 2019. PMID: 31220560 Clinical Trial.
-
Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial.Zhong Xi Yi Jie He Xue Bao. 2012 Apr;10(4):390-7. doi: 10.3736/jcim20120407. Zhong Xi Yi Jie He Xue Bao. 2012. PMID: 22500712 Clinical Trial.
-
Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer's Disease Therapy.Curr Top Med Chem. 2016;16(5):537-48. doi: 10.2174/1568026615666150813144003. Curr Top Med Chem. 2016. PMID: 26268330 Review.
Cited by
-
HIF-1 signalling pathway was identified as a potential new pathway for Icariin's treatment against Alzheimer's disease based on preclinical evidence and bioinformatics.Front Pharmacol. 2022 Dec 1;13:1066819. doi: 10.3389/fphar.2022.1066819. eCollection 2022. Front Pharmacol. 2022. PMID: 36532735 Free PMC article.
-
Transcranial Direct Current Stimulation Enhances Cognitive Function in Patients with Mild Cognitive Impairment and Early/Mid Alzheimer's Disease: A Systematic Review and Meta-Analysis.Brain Sci. 2022 Apr 27;12(5):562. doi: 10.3390/brainsci12050562. Brain Sci. 2022. PMID: 35624949 Free PMC article. Review.
-
An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer's Disease.Front Pharmacol. 2021 Nov 26;12:761661. doi: 10.3389/fphar.2021.761661. eCollection 2021. Front Pharmacol. 2021. PMID: 34899316 Free PMC article. Review.
-
Bu Shen Yi Sui Capsule Alleviates Neuroinflammation and Demyelination by Promoting Microglia toward M2 Polarization, Which Correlates with Changes in miR-124 and miR-155 in Experimental Autoimmune Encephalomyelitis.Oxid Med Cell Longev. 2021 Mar 16;2021:5521503. doi: 10.1155/2021/5521503. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33815654 Free PMC article.
-
Brain organoids are new tool for drug screening of neurological diseases.Neural Regen Res. 2023 Sep;18(9):1884-1889. doi: 10.4103/1673-5374.367983. Neural Regen Res. 2023. PMID: 36926704 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical